Nanofiber-based delivery of evodiamine impedes malignant properties of intrahepatic cholangiocarcinoma cells by targeting HDAC4 and restoring TPM1 transcription
Human Cell · 2024
DOI: 10.1007/s13577-024-01105-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von Rui Zou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Pancreatic Surgery Division 1, Hainan Cancer Hospital, No. 9, Changbin West Fourth Street, Xiuying District, Haikou, 570100, Hainan, Pe…. Hauptthemen laut MEDLINE: Tropomyosin, Nanofibers, Cholangiocarcinoma, Histone Deacetylases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Key R&D in Hainan Province, Hainan Province 'Nanhai Xinxing' Medical and Health Talent Platform Project and Research Fund of Hainan Cancer Hospital.
Abstract (Originalsprache)
The electrospun nanofiber system is correlated with high efficacy of drug delivery. This study aims to investigate the effect of nanofiber-based delivery of evodiamine, an indole alkaloid derived from Rutaceae plants Evodia rutaecarpa (Juss.) Benth, on intrahepatic cholangiocarcinoma (ICC), as well as to explore the molecular mechanisms. An electrospun nanofiber system carrying evodiamine was generated. Compared to evodiamine treatment alone, the nano-evodiamine exhibited more pronounced effects on suppressing proliferation, colony formation, invasiveness, migration, apoptosis resistance, cell cycle progression, and in vivo tumorigenesis of two ICC cell lines (HUCC-T1 and RBE). ICC cells exhibited increased expression of histone deacetylase 4 (HDAC4) while decreased tropomyosin 1 (TPM1). HDAC4 suppressed TPM1 expression by removing H3K9ac modifications from its promoter. Nano-evodiamine reduced HDAC4 protein levels in ICC cells, thus promoting transcription and expression of TPM1. Either overexpression of HDAC4 or downregulation of TPM1 negated the tumor-suppressive effects of nano-evodiamine. Collectively, this study demonstrates that the electrospun nanofiber system enhances the efficiency of evodiamine. Additionally, evodiamine suppresses the malignant properties of ICC cells. The findings may provide fresh insights into the application of electrospun nanofiber system for drug delivery and the effects of evodiamine on tumor suppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatobiliary Pancreatic Surgery Division 1, Hainan Cancer Hospital, No. 9, Changbin West Fourth Street, Xiuying District, Haikou, 570100, Hainan, People's Republic of China.
- Department of Integrated Traditional Chinese and Western Medicine, Hainan Cancer Hospital, Haikou, 570100, Hainan, People's Republic of China.
- Department of Gastrointestinal Surgery, Hainan Cancer Hospital, Haikou, 570100, Hainan, People's Republic of China.
- Hepatobiliary Pancreatic Surgery Division 1, Hainan Cancer Hospital, No. 9, Changbin West Fourth Street, Xiuying District, Haikou, 570100, Hainan, People's Republic of China. liduo3241@163.com.
- Medical College of Nankai University, Tianjin, 300071, People's Republic of China. qwen2708@163.com.
Förderung
- Key R&D in Hainan Province
- Hainan Province 'Nanhai Xinxing' Medical and Health Talent Platform Project and Research Fund of Hainan Cancer Hospital
Zitieren
APA
Zou, R., Wang, Y., Cai, Y., Xing, Z., Shao, Y., Li, D., & Qi, C. (2024). Nanofiber-based delivery of evodiamine impedes malignant properties of intrahepatic cholangiocarcinoma cells by targeting HDAC4 and restoring TPM1 transcription. Human Cell. https://doi.org/10.1007/s13577-024-01105-7
Vancouver
Zou R, Wang Y, Cai Y, Xing Z, Shao Y, Li D, et al. Nanofiber-based delivery of evodiamine impedes malignant properties of intrahepatic cholangiocarcinoma cells by targeting HDAC4 and restoring TPM1 transcription. Human Cell. 2024. doi:10.1007/s13577-024-01105-7
BibTeX
@article{Zou2024,
author = {Zou, Rui and Wang, Yiyao and Cai, Yaoqing and Xing, Zhenming and Shao, Yongfu and Li, Duo and Qi, Chunchun},
title = {Nanofiber-based delivery of evodiamine impedes malignant properties of intrahepatic cholangiocarcinoma cells by targeting HDAC4 and restoring TPM1 transcription},
journal = {Human Cell},
year = {2024},
doi = {10.1007/s13577-024-01105-7}
}
EUVIMED